Cargando…

Social mobilisation, drug coverage and compliance and adverse reactions in a Mass Drug Administration (MDA) Programme for the Elimination of Lymphatic Filariasis in Sri Lanka

BACKGROUND: In Sri Lanka filariasis is endemic in Southern, Western and North Western provinces covering eight districts designated as implementation units in the Programme for the Elimination of Lymphatic Filariasis (PELF). Despite control activities over sixty years including multidose diethylcarb...

Descripción completa

Detalles Bibliográficos
Autores principales: Weerasooriya, Mirani V, Yahathugoda, Channa T, Wickramasinghe, Darshana, Gunawardena, Kithsiri N, Dharmadasa, Rohan A, Vidanapathirana, Kanchana K, Weerasekara, Saman H, Samarawickrema, Wilfred A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2203982/
https://www.ncbi.nlm.nih.gov/pubmed/18005398
http://dx.doi.org/10.1186/1475-2883-6-11
_version_ 1782148406566715392
author Weerasooriya, Mirani V
Yahathugoda, Channa T
Wickramasinghe, Darshana
Gunawardena, Kithsiri N
Dharmadasa, Rohan A
Vidanapathirana, Kanchana K
Weerasekara, Saman H
Samarawickrema, Wilfred A
author_facet Weerasooriya, Mirani V
Yahathugoda, Channa T
Wickramasinghe, Darshana
Gunawardena, Kithsiri N
Dharmadasa, Rohan A
Vidanapathirana, Kanchana K
Weerasekara, Saman H
Samarawickrema, Wilfred A
author_sort Weerasooriya, Mirani V
collection PubMed
description BACKGROUND: In Sri Lanka filariasis is endemic in Southern, Western and North Western provinces covering eight districts designated as implementation units in the Programme for the Elimination of Lymphatic Filariasis (PELF). Despite control activities over sixty years including multidose diethylcarbamazine, 6 mg/kg treatment microfilaria rates had persisted at low levels. Following systematic social mobilisation the first MDA with DEC albendazole combination was conducted in 2002. METHODS: We investigated the extent social mobilisation had reached the people, their drug compliance and adverse reactions. Three localities were selected from each district to pick target population samples for pre-tested questionnaire. Three teams each with six people visited one district each day. One team worked from three starting points in one locality. A member applied eight part questionnaire to one family member totalling 150–160 people from one locality. Questions included social mobilisation, drug compliance and adverse reactions. RESULTS: Information was disseminated by television, radio, banners and leaflets, to a lesser extent by people. Information reached more people in the periphery than in Colombo. 35.2% from Colombo municipality were unaware of the MDA. Drug coverage was 79.6%, home delivery 71.7% and delivery centres 7.9%. 35.6% in Colombo district and 53.4% from Colombo municipality did not receive drugs. Drugs were consumed by 71.4%. 28.6% who did not comply included 20.4% who did not receive them. 91.4% showed no adverse reactions, 7.5% were mild, 1.1% recovered with home remedies. CONCLUSION: Drug compliance showed significant positive correlation with awareness of the MDA. Door to door delivery was more successful than delivery from centres. More delivery centres conveniently located would have rectified this disparity. Poor awareness and compliance in Colombo and urban areas could be rectified with separate strategy for urban areas. More time for MDA and trained adequate manpower would ensure coverage to achieve elimination.
format Text
id pubmed-2203982
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-22039822008-01-17 Social mobilisation, drug coverage and compliance and adverse reactions in a Mass Drug Administration (MDA) Programme for the Elimination of Lymphatic Filariasis in Sri Lanka Weerasooriya, Mirani V Yahathugoda, Channa T Wickramasinghe, Darshana Gunawardena, Kithsiri N Dharmadasa, Rohan A Vidanapathirana, Kanchana K Weerasekara, Saman H Samarawickrema, Wilfred A Filaria J Research BACKGROUND: In Sri Lanka filariasis is endemic in Southern, Western and North Western provinces covering eight districts designated as implementation units in the Programme for the Elimination of Lymphatic Filariasis (PELF). Despite control activities over sixty years including multidose diethylcarbamazine, 6 mg/kg treatment microfilaria rates had persisted at low levels. Following systematic social mobilisation the first MDA with DEC albendazole combination was conducted in 2002. METHODS: We investigated the extent social mobilisation had reached the people, their drug compliance and adverse reactions. Three localities were selected from each district to pick target population samples for pre-tested questionnaire. Three teams each with six people visited one district each day. One team worked from three starting points in one locality. A member applied eight part questionnaire to one family member totalling 150–160 people from one locality. Questions included social mobilisation, drug compliance and adverse reactions. RESULTS: Information was disseminated by television, radio, banners and leaflets, to a lesser extent by people. Information reached more people in the periphery than in Colombo. 35.2% from Colombo municipality were unaware of the MDA. Drug coverage was 79.6%, home delivery 71.7% and delivery centres 7.9%. 35.6% in Colombo district and 53.4% from Colombo municipality did not receive drugs. Drugs were consumed by 71.4%. 28.6% who did not comply included 20.4% who did not receive them. 91.4% showed no adverse reactions, 7.5% were mild, 1.1% recovered with home remedies. CONCLUSION: Drug compliance showed significant positive correlation with awareness of the MDA. Door to door delivery was more successful than delivery from centres. More delivery centres conveniently located would have rectified this disparity. Poor awareness and compliance in Colombo and urban areas could be rectified with separate strategy for urban areas. More time for MDA and trained adequate manpower would ensure coverage to achieve elimination. BioMed Central 2007-11-15 /pmc/articles/PMC2203982/ /pubmed/18005398 http://dx.doi.org/10.1186/1475-2883-6-11 Text en Copyright © 2007 Weerasooriya et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Weerasooriya, Mirani V
Yahathugoda, Channa T
Wickramasinghe, Darshana
Gunawardena, Kithsiri N
Dharmadasa, Rohan A
Vidanapathirana, Kanchana K
Weerasekara, Saman H
Samarawickrema, Wilfred A
Social mobilisation, drug coverage and compliance and adverse reactions in a Mass Drug Administration (MDA) Programme for the Elimination of Lymphatic Filariasis in Sri Lanka
title Social mobilisation, drug coverage and compliance and adverse reactions in a Mass Drug Administration (MDA) Programme for the Elimination of Lymphatic Filariasis in Sri Lanka
title_full Social mobilisation, drug coverage and compliance and adverse reactions in a Mass Drug Administration (MDA) Programme for the Elimination of Lymphatic Filariasis in Sri Lanka
title_fullStr Social mobilisation, drug coverage and compliance and adverse reactions in a Mass Drug Administration (MDA) Programme for the Elimination of Lymphatic Filariasis in Sri Lanka
title_full_unstemmed Social mobilisation, drug coverage and compliance and adverse reactions in a Mass Drug Administration (MDA) Programme for the Elimination of Lymphatic Filariasis in Sri Lanka
title_short Social mobilisation, drug coverage and compliance and adverse reactions in a Mass Drug Administration (MDA) Programme for the Elimination of Lymphatic Filariasis in Sri Lanka
title_sort social mobilisation, drug coverage and compliance and adverse reactions in a mass drug administration (mda) programme for the elimination of lymphatic filariasis in sri lanka
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2203982/
https://www.ncbi.nlm.nih.gov/pubmed/18005398
http://dx.doi.org/10.1186/1475-2883-6-11
work_keys_str_mv AT weerasooriyamiraniv socialmobilisationdrugcoverageandcomplianceandadversereactionsinamassdrugadministrationmdaprogrammefortheeliminationoflymphaticfilariasisinsrilanka
AT yahathugodachannat socialmobilisationdrugcoverageandcomplianceandadversereactionsinamassdrugadministrationmdaprogrammefortheeliminationoflymphaticfilariasisinsrilanka
AT wickramasinghedarshana socialmobilisationdrugcoverageandcomplianceandadversereactionsinamassdrugadministrationmdaprogrammefortheeliminationoflymphaticfilariasisinsrilanka
AT gunawardenakithsirin socialmobilisationdrugcoverageandcomplianceandadversereactionsinamassdrugadministrationmdaprogrammefortheeliminationoflymphaticfilariasisinsrilanka
AT dharmadasarohana socialmobilisationdrugcoverageandcomplianceandadversereactionsinamassdrugadministrationmdaprogrammefortheeliminationoflymphaticfilariasisinsrilanka
AT vidanapathiranakanchanak socialmobilisationdrugcoverageandcomplianceandadversereactionsinamassdrugadministrationmdaprogrammefortheeliminationoflymphaticfilariasisinsrilanka
AT weerasekarasamanh socialmobilisationdrugcoverageandcomplianceandadversereactionsinamassdrugadministrationmdaprogrammefortheeliminationoflymphaticfilariasisinsrilanka
AT samarawickremawilfreda socialmobilisationdrugcoverageandcomplianceandadversereactionsinamassdrugadministrationmdaprogrammefortheeliminationoflymphaticfilariasisinsrilanka